BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/23/19 Advaxis (ADXS) Axalimogene Filolisbac for Cervical Cancer Subscribers Only Subscribers Only Subscribers Only
1/23/19 XBiotech (XBIT) Bermekimab for Hidradenitis Suppurativa Subscribers Only Subscribers Only Subscribers Only
1/22/19 Lux Biosciences Voclosporin Ophthalmic Solution (VOS) for Dry Eye (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
1/22/19 GlaxoSmithKline (GSK) Zejula for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
1/22/19 TG Therapeutics (TGTX) TGR-1202 for Marginal Zone Lymphoma - NHL Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 01/25/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
Now - 01/25/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
Now - 01/25/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
Now - 01/25/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
Now - 01/25/19 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
Back to the top Back to the top